Page last updated: 2024-08-23

raloxifene hydrochloride and Adverse Drug Event

raloxifene hydrochloride has been researched along with Adverse Drug Event in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Landfeldt, E; Lang, A; Robbins, S; Ström, O	1
Jacobsen, DE; Melis, RJ; Olde Rikkert, MG; Verhaar, HJ	1
Cassels, A; Cole, C; Hughes, MA; Lexchin, J; McCormack, JP; Mintzes, B	1
González Macías, J; Olmos Martínez, JM	1

Reviews

1 review(s) available for raloxifene hydrochloride and Adverse Drug Event

Article	Year
[Osteoporosis in cancer survivors]. Medicina clinica, 2007, Nov-10, Volume: 129, Issue:17 Topics: Age Factors; Aged; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Drug-Related Side Effects and Adverse Reactions; Female; Fractures, Bone; Humans; Hypogonadism; Male; Middle Aged; Neoplasms; Osteoporosis; Prostatic Neoplasms; Radiotherapy; Raloxifene Hydrochloride; Retrospective Studies; Risk Factors	2007

Article

Year

[Osteoporosis in cancer survivors].

Medicina clinica, 2007, Nov-10, Volume: 129, Issue:17

Topics: Age Factors; Aged; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Drug-Related Side Effects and Adverse Reactions; Female; Fractures, Bone; Humans; Hypogonadism; Male; Middle Aged; Neoplasms; Osteoporosis; Prostatic Neoplasms; Radiotherapy; Raloxifene Hydrochloride; Retrospective Studies; Risk Factors

2007

Trials

1 trial(s) available for raloxifene hydrochloride and Adverse Drug Event

Article	Year
Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial. Journal of the American Medical Directors Association, 2012, Volume: 13, Issue:2 Topics: Absorptiometry, Photon; Academic Medical Centers; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Bone Density Conservation Agents; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Middle Aged; Netherlands; Norpregnenes; Osteoporosis, Postmenopausal; Patient Safety; Raloxifene Hydrochloride; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome	2012

Article

Year

Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial.

Journal of the American Medical Directors Association, 2012, Volume: 13, Issue:2

Topics: Absorptiometry, Photon; Academic Medical Centers; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Bone Density Conservation Agents; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Middle Aged; Netherlands; Norpregnenes; Osteoporosis, Postmenopausal; Patient Safety; Raloxifene Hydrochloride; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome

2012

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Adverse Drug Event

Article	Year
Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA). Calcified tissue international, 2011, Volume: 89, Issue:3 Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Etidronic Acid; Female; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Male; Medication Adherence; Middle Aged; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Registries; Retrospective Studies; Risedronic Acid; Sweden; Thiophenes	2011
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, Apr-29, Volume: 168, Issue:9 Topics: Acetamides; Advertising; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antiviral Agents; Atorvastatin; Bibliometrics; Canada; Celecoxib; Cholinesterase Inhibitors; Consumer Product Safety; Disclosure; Donepezil; Drug Industry; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Estrogen Antagonists; Heptanoic Acids; Humans; Indans; Newspapers as Topic; Oseltamivir; Patient Education as Topic; Piperidines; Pyrazoles; Pyrroles; Raloxifene Hydrochloride; Sulfonamides	2003

Article

Year

Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).

Calcified tissue international, 2011, Volume: 89, Issue:3

Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Etidronic Acid; Female; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Male; Medication Adherence; Middle Aged; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Registries; Retrospective Studies; Risedronic Acid; Sweden; Thiophenes

2011

Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, Apr-29, Volume: 168, Issue:9

Topics: Acetamides; Advertising; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antiviral Agents; Atorvastatin; Bibliometrics; Canada; Celecoxib; Cholinesterase Inhibitors; Consumer Product Safety; Disclosure; Donepezil; Drug Industry; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Estrogen Antagonists; Heptanoic Acids; Humans; Indans; Newspapers as Topic; Oseltamivir; Patient Education as Topic; Piperidines; Pyrazoles; Pyrroles; Raloxifene Hydrochloride; Sulfonamides

2003